Article
NHERF1/EBP50 is a new marker in colorectal cancer.
Neoplasia (New York, N.Y.) - 1 Dec 2010
Hayashi Yuho, Molina Jennifer R, Hamilton Stanley R, Georgescu Maria-Magdalena
Abstract excerpt
Human colorectal cancer (CRC) arises from activating mutations in the Wnt/β-catenin pathway that converge with additional molecular changes to shape tumor development and patient prognosis. We report here that Na(+)/H(+) exchanger 3 regulating factor 1 (NHERF1)/EBP50, an adaptor molecule that interacts with β-catenin, undergoes successive alterations during the colorectal adenoma-to-carcinoma transition, ranging...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
